1.0 Credit / HIV/AIDS, Infectious Disease

The Current Landscape of Ending the HIV Epidemic: A Focus on PrEP

Updates in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease and the Role of the Oncology Pharmacist

Tumor-Infiltrating Lymphocytes: Infiltrating the Boundaries of Cancer Care in Solid Tumors Through a Managed Care Lens

Treatment of ALS: Examining the Role of Current and Emerging Therapies

2022 New Specialty Drug and Biosimilar Approvals

Best Practices to Individualize and Optimize Diabetes Management With Integrated Continuous Glucose Monitoring Devices

Breaking Down Barriers to Improve Outcomes and Access to Integrated Continuous Glucose Monitoring Devices

Continuous Glucose Monitoring: Moving Beyond A1C for Diabetes Management

Employing Current GOLD Guidelines for Patients With Chronic Obstructive Pulmonary Disease: Considerations for Pharmacists to Prevent Exacerbations and Improve Clinical Outcomes

Exploring Treatment Options in Fabry Disease to Address Management Gaps and Improve Patient Outcomes

JAK Inhibitors and the Evolving Treatment Landscape in Atopic Dermatitis and Alopecia Areata

Optimizing Administration of CAR T-Cell Therapy in Multiple Myeloma Through Pharmacist Interventions

Innovations in Cancer Care: Examining the Emerging Role of Bispecific Antibodies in Relapsed/Refractory Lymphoma and Multiple Myeloma

Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs

Continuing the Conversation: Exploring the Emerging Treatment Landscape of Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on Novel Immunotherapies

Optimizing the Use of Targeted Therapies for the Treatment of ROS1-Rearranged and KRAS-Mutant Non−Small Cell Lung Cancer

The Benefits and Challenges of Targeted Treatments in Severe and Uncontrolled Asthma: Opportunities in Managed Care

Redefining Optimal Therapy for Patients with Heart Failure with Reduced Ejection Fraction: Integrating New Guidelines, Emerging Agents, and Pharmacist-led Transitions of Care

Advances in the Treatment of Non-Melanoma Skin Cancers: The Role of Immune Checkpoint Inhibitors

IV Iron Replacement Therapy to Mitigate the Burden of Iron Deficiency Anemia: Updates for Health-System Pharmacists

An In-depth Look at PARP Inhibitors and Their Role in the Treatment of Ovarian Cancer

Exploring the New Standard of Care for the Frontline Treatment of Non-Small Cell Lung Cancer: A Focus on Immunotherapy

Exploring the Emerging Treatment Landscape of Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on Novel Immunotherapies

Exploring the Efficacy and Safety of Iron Replacement Therapies for the Treatment of Iron Deficiency Anemia in Chronic Kidney Disease: A Review for Health-System Pharmacists

1.5 Credits / Breast Cancer, Oncology, Women’s Health 

Exploring New and Emerging Oral Treatments in HR-Positive, HER2-Negative Breast Cancer: A Primer for Health-System Pharmacists

Managed Care Considerations and Implementation Strategies for Biosimilars in Oncology

Advances in High-Risk Myelodysplastic Syndromes: Insights and Application for Managed Care With ASH Annual Meeting Coverage

2022 ASH Annual Meeting Coverage—Recent Developments in Diffuse Large B-Cell Lymphoma: Insights and Application for Managed Care

Hidradenitis Suppurativa: Pharmacist Considerations for the Emerging Treatment Options

A Pharmacist’s Guide to the Use of Targeted Therapy for HER2-Positive Breast Cancer

Making the Most of Anti-Androgen Therapies in Prostate Cancer Through Pharmacist Interventions

Management Considerations for Hidradenitis Suppurativa and the Emerging Role of Biologics in Treatment

Advances in the Treatment of Immune Thrombocytopenia: Strategies for Optimizing Clinical and Patient Outcomes

Managed Care Insights on Optimizing the Use of BCMA-Targeted Treatments in Multiple Myeloma

Management of Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): Pharmacist-Led Strategies for Optimizing Clinical and Patient Outcomes

Understanding the Role of BCMA-Directed Therapy in the Management of Relapsed/Refractory Multiple Myeloma

Clinical Conversations: Novel Approaches for the Treatment of cGVHD With Newly Approved and Emerging Therapies 

ESMO Congress 2022: Advances and Best Practices for Managed Care Pharmacists in the Treatment of Metastatic Head and Neck Squamous cell Carcinoma

Advances in Prostate Cancer: An Evidence-based Review for Managed Care Professionals

An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC

Therapeutic Strategies for Bipolar Disorder: Recognizing the Intricacies in Disease Management and Considerations for Pharmacists Across Practice Settings

Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists

1.5 Credits / Gastroenterology, Immunology

Integrating Sphingosine-1-Phosphate (S1P) Receptor Modulators in the Management of Ulcerative Colitis: The Pharmacist’s Role on the Interdisciplinary Team

Optimizing Care of Patients on Immune Checkpoint Inhibitors: An Oncology Primer for Community Pharmacists

Expert Insight on Advances in the Therapeutic Landscape of Hypertrophic Cardiomyopathy

Strategies to Improve the Management of Migraine: Clinical Updates for Pharmacists and Patient-Case Review

Advances in the Use of Immune Checkpoint Inhibitors to Treat Non-Melanoma Skin Cancers: Updates for Oncology Pharmacists

Exploring the Evolving Treatment Landscape for Patients With Waldenström Macroglobulinemia 

Advancing Treatment Options for Endometrial Cancer: Updates for Pharmacists

Clinical Updates in the Treatment of HER2-Positive Breast Cancer

Updates on the Utility of PARP Inhibitors in the Treatment of Ovarian Cancer: Opportunities for Pharmacists to Improve Patient Care

Acute Myeloid Leukemia: Novel Targeted Therapies and the Role of the Pharmacist 

Antibody-Drug Conjugates (ADCs): The Implications of Emerging Trends on Oncology Pharmacy Practice

The Role of Immune Checkpoint Inhibitors in Cutaneous Melanoma: Evaluating Therapeutic Trends

Oral Chemotherapy Parity Legislation: Opportunities for Cancer Care Equity

Utilizing Targeted Agents for Treatment of HFrEF: The Role of the Pharmacist in Medication Selection and Therapy Management

1 Credit / Immunization, Infectious Disease

Recent Advancements in COVID-19 Vaccination: An Update for Pharmacists (Pharmacy Technician Credit)

Recent Advancements in COVID-19 Vaccination: An Update for Pharmacists (Pharmacist Credit)

Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer

Investigating the Optimal Use of Novel Immunotherapies for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recognizing Rett Syndrome: Managed Care Insights on Disease Burden

1.5 Credits / Immunology, Neurology, Rare Diseases

Advancements in Myasthenia Gravis Treatment: Supporting Access Through Value-Based Care Models

Developing Clinical Pathways for Treatment of Advanced/Metastatic ccRCC in Managed Care Pharmacy: Opportunities, Challenges, and Best Practices

The Emerging Treatment Landscape for the Management of Sickle Cell Disease: What’s on the Horizon

Improving Clinical Outcomes in Clostridioides difficile: Exploring Advancements in Therapy to Treat Infection and Mitigate Recurrence

The Role of the Pharmacist in Shingles Vaccination Recommendations: The Critical Need to Educate, Motivate, and Increase Access, featuring Patient Counseling Video Vignettes (Pharmacy Technician Credit)

The Role of the Pharmacist in Shingles Vaccination Recommendations: The Critical Need to Educate, Motivate, and Increase Access, featuring Patient Counseling Video Vignettes

Challenges of Treating Epilepsy Syndromes and Opportunities in an Expanding Therapeutic Landscape: A Managed Care Perspective

OTC Treatment Strategies to Optimize the Management of Allergic Conjunctivitis (Pharmacy Technician Credit)

OTC Treatment Strategies to Optimize the Management of Allergic Conjunctivitis (Pharmacist Credit)

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

Exploring Treatment Advances in Plaque Psoriasis and the Role of the Pharmacist in Patient Outcomes

Managed Care Approaches in Optimizing the Impact of PARP Inhibitors on Resource Utilization and Clinical Outcomes in Ovarian Cancer

ROS1-Targeted Treatments in NSCLC: Updates and Best Practices for Managed Care

Challenging the Treatment Paradigm for HER2-low Breast Cancer: Managed Care Perspectives

Advancements in Treatment Options for Age-Related Macular Degeneration and Diabetic Macular Edema, featuring a Patient Perspective

1.5 Credits / Endocrinology, Women's Health

Evaluating Novel Nonhormonal Approaches for the Treatment of Menopausal Vasomotor Symptoms

The Evolving Treatment Landscape for HR+/HER2- Breast Cancer: Updates and Considerations for Managed Care

Targeting the Sickle Cell Disease Cascade and the Shifting Approach to Care

Influenza Vaccine Recommendations for the 2022-2023 Season: An Update for Pharmacists

Exploring Primary Immunodeficiency Disorder Treatment: A Review of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin Therapies

HIV Therapy: Addressing Unanswered Questions to Optimize Care

2.0 Credits / Endocrinology, Ophthalmology

Continuing the Conversation: Seeing Improvements in the Management of Age-Related Macular Degeneration and Diabetic Macular Edema With Pharmacist Involvement

Individualizing the Management of Primary Immunodeficiency Disorders: Considerations in the Selection of Intravenous Immunoglobulin or Subcutaneous Immunoglobulin

Targeting the Clinical Course of Hypertrophic Cardiomyopathy: Keeping a Beat on New and Emerging Therapies 

Moving Beyond Medications: Practices to Provide Appropriate Care for People Living With HIV

Back to Basics: Initiating and Monitoring HIV Treatment

Improving Uptake and Access to HIV PrEP: Managed Care Considerations

On the Frontiers, Front Lines, and Fringes of PrEP for HIV Prevention

1.5 Credits / Cystic Fibrosis, Respiratory

Recent Advancements in the Management of Cystic Fibrosis: The Role of Health-System Pharmacists

1.5 Credits / HIV/AIDS, Infectious Disease

An Interprofessional Discussion on How to Overcome Barriers and Improve Access to HIV PrEP

Deprescribing: Less Is More

Combatting the Monkeypox Outbreak: What Pharmacists Need to Know

The Impact of PCSK9 Modulation on Cardiovascular Outcomes: Recent Advances and the Managed Care Implications

Emerging Care Management Strategies for Severe Asthma: Integrating Biologic Therapy

A Beginner’s Guide to Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Care

Updates in the Targeted Treatment and Management of Unresectable or Metastatic Cholangiocarcinoma for Managed Care Pharmacists

A Supplement to the American Journal of Managed Care: Advancing Alzheimer Disease Treatment: Updates and Insights for Managed Care

Assessing Novel Approaches in the Treatment of Beta Thalassemia

Health Care Disparities in Management of Anemia in Chronic Kidney Disease

Continuing Education